FOXO Technologies Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a FOXO research report →
Price Chart
About the company
FOXO Technologies Inc. operates as a technology platform company primarily focused on translating longevity science into practical applications for the life insurance sector. The firm is actively creating products and services that integrate scientific understanding of longevity with life insurance offerings.
- CEO
- Seamus Lagan
- IPO
- 2022
- Employees
- 230
- HQ
- West Palm Beach, FL, US
Get TickerSpark's AI analysis on FOXO
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $1.34M
- P/E
- 0.02
- PEG
- 0.00
- P/S
- 0.07
- P/B
- 0.19
- EV/EBITDA
- -46.64
- Div Yield
- 0.00%
- Gross Margin
- 47.49%
- Op Margin
- -4.91%
- Net Margin
- -25.77%
- ROE
- -43.80%
- ROIC
- -3.65%
Latest fiscal year · YoY change
- Revenue
- $16.37M+304.0%
- Gross Profit
- $8.04M+412.9%
- Op Income
- $-10,329,214
- Net Income
- $-12,430,390-0.2%
- EPS
- $-0.13+86.0%
- OCF Growth
- -36.1%
- FCF Growth
- -38.2%
- 52W High
- $9.00
- 52W Low
- $0.02
- 50D MA
- $0.09
- 200D MA
- $0.22
- Beta
- 2.53
- RSI (14)
- 55
- Avg Volume
- 10.05K
No earnings-call transcripts are available for FOXO yet.
- Free Float
- 14.2%
- Shares Outstanding
- 10.00M
- Float Shares
- 1.42M
of shares held by institutions
11 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Corbin Capital Partners, L.P. | 27.48K | 0 |
| Atalaya Capital Management LP | 11.78K | 0 |
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Sep 10, 24 | Langley Trevor | other | 0 |
| Sep 10, 24 | Lagan Seamus | other | 0 |
| Jul 22, 24 | Kr8 ai Inc. | sell | 1,300,000 |
| Jul 22, 24 | WHITE MARK BRIAN | sell | 1,300,000 |
| Jul 22, 24 | WARD MARTIN CHRISTOPHER | sell | 1,300,000 |
| Feb 6, 24 | WARD MARTIN CHRISTOPHER | sell | 250,000 |
| Feb 6, 24 | WHITE MARK BRIAN | sell | 250,000 |
| Jan 19, 24 | Kr8 ai Inc. | other | 0 |
| Jan 19, 24 | Christopher Spencer C | other | 0 |
| Jan 19, 24 | WHITE MARK BRIAN | other | 1,300,000 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our FOXO coverage
Recent articles, reports, and earnings notes.
No research on FOXO yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate FOXO report →FOXO TECHNOLOGIES INC.'S SUBSIDIARY VECTOR BIOSOURCE, INC.
globenewswire.com · Jul 29
FOXO TECHNOLOGIES INC. CEO SEAMUS LAGAN PROVIDES MID-YEAR UPDATE TO SHAREHOLDERS
globenewswire.com · Jul 6
FOXO TECHNOLOGIES INC. CEO SEAMUS LAGAN PROVIDES MID-YEAR UPDATE TO SHAREHOLDERS
globenewswire.com · Jul 6
FOXO TECHNOLOGIES INC. ANNOUNCES COMPLETION OF REVERSE STOCK SPLIT
globenewswire.com · Jul 1
FOXO TECHNOLOGIES, INC., FORMS STRATEGIC PARTNERSHIP WITH LONGEVITYFP TECHNOLOGIES, LLC.
globenewswire.com · May 28
FOXO TECHNOLOGIES, INC., FORMS STRATEGIC PARTNERSHIP WITH LONGEVITYFP TECHNOLOGIES, LLC. TO COMMERCIALIZE FOXO’S EPIGENETICS TECHNOLOGY
globenewswire.com · May 28
FOXO Technologies Inc. Subsidiary, Big South Fork Medical Center, Expands Clinical Capabilities
globenewswire.com · Jan 20
FOXO TECHNOLOGIES INC. CEO SEAMUS LAGAN PROVIDES YEAR-END REVIEW TO SHAREHOLDERS
globenewswire.com · Dec 15
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.